Evidence map›Paper›PMID 29374027›Full record

ArticleThe Journal of experimental medicine2018

Initiation of inflammatory tumorigenesis by CTLA4 insufficiency due to type 2 cytokines.

Jason Miska, Jen Bon Lui, Kevin H Toomer, Priyadharshini Devarajan, Xiaodong Cai, JeanMarie Houghton, Diana M Lopez, Maria T Abreu, Gaofeng Wang, Zhibin Chen

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. A Prognostic Riskscore Model Related toInternational journal of genomics · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Two Distinct Etiologies of Gastric Cancer: Infection and Autoimmunity.Frontiers in cell and developmental biology · 2021
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jason MiskaDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL.ORCID 0000-0001-9608-2810
Jen Bon LuiDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL.
Kevin H ToomerDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL.
Priyadharshini DevarajanDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL.
Xiaodong CaiDepartment of Electrical and Computer Engineering, University of Miami, Coral Gables, FL.
JeanMarie HoughtonDivision of Gastroenterology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA.
Diana M LopezDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL.
Maria T AbreuDivision of Gastroenterology, Department of Medicine, University of Miami, Miami, FL.
Gaofeng WangHussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL.
Zhibin ChenDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL zchen@med.miami.edu.ORCID 0000-0002-2865-8416
University of Miami · USUniversity of Massachusetts Chan Medical School · US

Funding

Role of TLR4 in Colitis Associated NeoplasiaR01DK099076 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Maria Teresa Abreu · 2014 to 2026
$4.7M
TRAINING PROGRAM IN ONCOGENESIS &DEVELOPMENT BIOLOGYT32CA080621 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI EKLUND, ELIZABETH ANN · 2001 to 2018
$4.1M
Role of Th1/17 in gastric tumor initiation triggered by CTLA4 dysregulationR21CA178675 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CHEN, ZHIBIN · 2013 to 2014
$360k
NCI NIH HHS R21 CA178675NCI NIH HHS T32 CA080621NIDDK NIH HHS R01 DK099076
6 · The paper itself

Abstract

Genetically predisposed CTLA4 insufficiency in humans is associated with gastric cancer development, which is paradoxical to the prototypical role of CTLA4 in suppressing antitumor immunity. CTLA4 is a critical immune checkpoint against autoimmune disorders. Autoimmunity has been implicated in protumor or antitumor activities. Here, we show that CTLA4 insufficiency initiates de novo tumorigenesis in the mouse stomach through inflammation triggered by host-intrinsic immune dysregulation rather than microbiota, with age-associated progression to malignancy accompanied by epigenetic dysregulation. The inflammatory tumorigenesis required CD4 T cells, but not the T

Indexed as

AdenocarcinomaAnimalsAntibodiesAutoimmunityCarcinogenesisCTLA-4 AntigenCytokinesEpigenesis, GeneticHumansInflammationIntercellular Signaling Peptides and ProteinsInterferon-gammaInterleukinsMice, Inbred BALB CMice, Inbred C57BLMicrobiotaAntibodiesCTLA-4 AntigenCytokinesIntercellular Signaling Peptides and ProteinsInterferon-gammaInterleukinsPeptidesspasmolytic polypeptide

Identifiers

PMID29374027
PMCPMC5839767
OpenAlexW2790748534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.